These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19717873)

  • 1. Vi conjugate typhoid vaccine.
    Garg SP
    Indian Pediatr; 2009 Aug; 46(8):736-7. PubMed ID: 19717873
    [No Abstract]   [Full Text] [Related]  

  • 2. Typhoid vaccine(s)--to give or not to give.
    Kalra A; Vashishtha VM
    Indian Pediatr; 2009 Aug; 46(8):733-4; author reply 734-5. PubMed ID: 19717868
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.
    Mai NL; Phan VB; Vo AH; Tran CT; Lin FY; Bryla DA; Chu C; Schiloach J; Robbins JB; Schneerson R; Szu SC
    N Engl J Med; 2003 Oct; 349(14):1390-1. PubMed ID: 14523155
    [No Abstract]   [Full Text] [Related]  

  • 4. Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
    Pulickal AS; Pollard AJ
    Expert Rev Vaccines; 2007 Jun; 6(3):293-5. PubMed ID: 17542742
    [No Abstract]   [Full Text] [Related]  

  • 5. Typhoid vaccine.
    Boob RG
    Indian Pediatr; 1995 Oct; 32(10):1138. PubMed ID: 8984062
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined (associated) immunization against typhoid, typhus and plague].
    Gapochko KG; Misnikov OP; Kolkov VF; Kekcheeva NG; Semenova BN; Titova TS
    Voen Med Zh; 1994 Apr; (4):42-6, 79. PubMed ID: 8091696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Advisory Committee on Immunization (NACI). Supplementary statement on Typhim VI polysaccharide capsular vaccine.
    Can Commun Dis Rep; 1995 Nov; 21(22):197-200. PubMed ID: 8574205
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of Vi conjugate - a new generation of typhoid vaccine.
    Szu SC
    Expert Rev Vaccines; 2013 Nov; 12(11):1273-86. PubMed ID: 24156285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field effectiveness of Vi polysaccharide typhoid vaccine in the People's Republic of China.
    Arya SC
    J Infect Dis; 2002 Mar; 185(6):845; author reply 845-6. PubMed ID: 11920305
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity and safety of Vi capsular polysaccharide typhoid vaccine in healthy persons in Korea.
    Lim SM; Jung HS; Kim MJ; Park DW; Kim WJ; Cheong HJ; Park SC; Lee KC; Shin YK; Tan HK; Kim SL; Sohn JW
    J Microbiol Biotechnol; 2007 Apr; 17(4):611-5. PubMed ID: 18051272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever.
    Froeschle JE; Decker MD
    Vaccine; 2010 Feb; 28(6):1451-3. PubMed ID: 20003920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Schwartz E
    N Engl J Med; 2009 Nov; 361(22):2191-2; author reply 2192-3. PubMed ID: 19950412
    [No Abstract]   [Full Text] [Related]  

  • 13. Typhim Vi vaccine against typhoid fever: a clinical trial in Kenya.
    Mirza NB; Wamola IA; Estambale BA; Mbithi E; Poillet M
    East Afr Med J; 1995 Mar; 72(3):162-4. PubMed ID: 7796767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of safety and immunogenicity of a Vi polysaccharide typhoid vaccine with a whole-cell killed vaccine in Malaysian Air Force recruits.
    Panchanathan V; Kumar S; Yeap W; Devi S; Ismail R; Sarijan S; Sam SM; Jusoh Z; Nordin S; Leboulleux D; Pang T
    Bull World Health Organ; 2001; 79(9):811-7. PubMed ID: 11584728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on: development of Vi conjugate--a new generation of typhoid vaccine.
    Arya SC; Agarwal N
    Expert Rev Vaccines; 2014 Apr; 13(4):453-4. PubMed ID: 24555515
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of Typhim Vi vaccine in a postmarketing observational study.
    Marcus LC; Froeschle JE; Hill DR; Wolfe MS; Maus D; Connor B; Acosta AM; Rensimer ER; Roberts A; Dardick K
    J Travel Med; 2007; 14(6):386-91. PubMed ID: 17995534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy.
    Bahl R; Sinha A; Poulos C; Whittington D; Sazawal S; Kumar R; Mahalanabis D; Acosta CJ; Clemens JD; Bhan MK
    J Health Popul Nutr; 2004 Sep; 22(3):304-10. PubMed ID: 15609783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunities for Typhoid Vaccination in India.
    Srinivasan M; Sindhu KN; John J; Kang G
    Indian Pediatr; 2019 Jun; 56(6):453-458. PubMed ID: 31278221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugate typhoid vaccine(s) in the Indian context.
    Mathew JL
    Indian Pediatr; 2009 Feb; 46(2):182-4. PubMed ID: 19242042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.